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ABSTRACT
Previous compositional studies of pre-mRNA
processing complexes have been performed
in vitro on synthetic pre-mRNAs containing a single
intron. To provide a more comprehensive list of
polypeptides associated with the pre-mRNA splicing
apparatus, we have determined the composition of
the bulk pre-mRNA processing machinery in living
cells. We purified endogenous nuclear pre-mRNA
processing complexes from human and chicken
cells comprising the massive (`200S) supraspliceo-
somes (a.k.a. polyspliceosomes). As expected, RNA
components include a heterogeneous mixture of
pre-mRNAs and the five spliceosomal snRNAs. In
addition to known pre-mRNA splicing factors, 50 end
binding factors, 30 end processing factors, mRNA
export factors, hnRNPs and other RNA binding
proteins, the protein components identified by
mass spectrometry include RNA adenosine deami-
nases and several novel factors. Intriguingly, our
purifiedsupraspliceosomesalsocontainanumberof
structural proteins, nucleoporins, chromatin remod-
eling factors and several novel proteins that were
absent from splicing complexes assembled in vitro.
These in vivo analyses bring the total number of
factors associated with pre-mRNA to well over 300,
and represent the most comprehensive analysis of
the pre-mRNA processing machinery to date.
INTRODUCTION
Eukaryotic RNA polymerase II (RNA Pol II) transcripts
are matured through a highly coordinated program of
processing steps prior to export from the nucleus to the
cytoplasm where they are translated into protein by the
ribosome (1–5). These pre-mRNA processing events
include 50 end modiﬁcation by 7-methyl-guanosine cap
addition and binding of the nuclear cap binding complex,
intron removal by the spliceosome, 30 end cleavage and
poly-adenosine tail addition, transcript-speciﬁc modiﬁca-
tions such as adenosine deamination and binding of
speciﬁc protein factors to regulate and promote mature
mRNA export from the nucleus. Coordination of these
events involves interaction between the machineries
involved in each process. For example, the RNA Pol II
transcription complex communicates and interacts exten-
sively with the 50 end capping, pre-mRNA splicing and
30 end processing machineries (1).
While native pre-mRNAs contain multiple, often
extremely large introns, in vitro pre-mRNA splicing
reactions are carried out using synthetic pre-mRNA
fragments containing a single, eﬃciently spliced intron of
a size compatible with acrylamide gel electrophoresis
analysis. Although the core pre-mRNA processing
machinery will likely be very similar between diﬀerent
transcripts as well as for the multiple introns contained
within a single transcript, the bulk pre-mRNA processing
machinery puriﬁed from its native context is likely to
contain a more comprehensive sample of the polypeptides
required for or participating in the splicing of pre-mRNA
in vertebrate cells.
Several groups have puriﬁed and characterized spliceo-
somes formed on model vertebrate pre-mRNAs in vitro
(6–8) and shown that they contain a remarkably large
number of associated polypeptides. Nevertheless, as these
synthetic precursors have generally been modiﬁed from
their natural state by internal deletions within the intron
and truncations of the exons, the pattern of associated
proteins is inevitably less complex than on the full-length,
generally multi-intronic precursors that exist in vivo.I n
addition, the spliceosomes puriﬁed from in vitro reactions
were assembled on pre-mRNAs derived from either the
adenovirus major late or b-globin loci. Thus, it is likely
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participate in pre-mRNA processing in vivo, yet are not
present in previously puriﬁed splicing complexes because
they are speciﬁc to one or more of the thousands of other
pre-mRNAs present in metazoan cells. Finally, the path-
way by which pre-mRNA processing complexes are
assembled in vitro using salt-extracted nuclear fractions
most likely bypasses many interactions relevant to this
process in vivo. Thus spliceosomes puriﬁed following
in vivo assembly are expected to contain additional
components that reﬂect the native pathway, but are
not required to eﬀect model intron removal in vitro.
Additionally, factors that assist in inter-spliceosome
interactions in multi-intron substrates will be absent
from mono-spliceosome puriﬁcations, and should be
present in in vivo-puriﬁed complexes.
Consistent with this view, other investigators have
shown that endogenous pre-mRNA is processed in
extremely large ribonucleoprotein particles, called supra-
spliceosomes (9–11) or polyspliceosomes (12). Biochemical
and structural analyses of these complexes have demon-
strated the presence of RNA Pol II transcripts (13,14) and
the pre-mRNA splicing machinery components (15,16) as
well as functional interactions that mirror those in active
splicing complexes assembled in vitro (12). The higher
order particles formed in vivo partly reﬂect the presence of
multiple introns, an average of eight per pre-mRNA (17)
with some transcripts possessing as many as 147 introns
[Nebulin (18)], that need to be faithfully removed prior to
nuclear export. In Figure 1, we present a schematic model
of the pre-mRNA processing pathway in vivo that
encompasses the concept of the supra/polyspliceosome.
Whether the individual ‘spliceosome’ moieties are formed
via stepwise snRNP assembly on individual introns (2) or
via pre-formed penta-snRNPs (19) in vertebrates is still a
matter of considerable debate, although recent chromatin
immunoprecipitation experiments in human cells provide
support for the penta-snRNP model (20).
With the goal of expanding our understanding of pre-
mRNA splicing as it occurs in intact cells, we have puriﬁed
the endogenous pre-mRNA processing machines from
HeLa cells and from chicken DT40 pre-B cells (21) on a
preparative scale and have deﬁned their RNA and
polypeptide compositions. We have chosen the chicken
DT40 system to compare with the HeLa system for a
number of reasons. First, we have shown that working
with this rapidly growing cell type, which possesses high
rates of homologous recombination, allows for down-
stream experimental ﬂexibility in epitope-tagging of other
genes (22). The evolutionary distance between human and
chicken will also allow us to assess the evolutionary
conservation of the machinery as well as validating novel
co-purifying factors. We show that these pre-mRNA
processing complexes contain spliced and unspliced
mRNAs, all ﬁve spliceosomal snRNAs and polypeptides
involved in all aspects of pre-mRNA processing from
transcription to nuclear export.
Although our strategy may not be sensitive enough to
identify very low abundance pre-mRNA-speciﬁc factors, it
has allowed us to probe more deeply into the general pre-
mRNA processing machinery present in vertebrate cells.
Indeed, when combined with the data from in vitro-
assembled spliceosome characterization and known splic-
ing factors not detected in any complexes previously
puriﬁed, we show there are at least 305 polypeptides
involved in or present during the processing of nuclear
pre-mRNA.
MATERIALS AND METHODS
Purification of HeLasupraspliceosomes
Ten liters of HeLa cells (purchased from the National Cell
Culture Center) were processed essentially as described
(11). Brieﬂy, cells were washed in PBS (137mM NaCl,
2.7mM KCl, 10mM Na2HPO4, 2mM KH2PO4) and
disrupted by mechanical breakage in a glass dounce
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Figure 1. Model describing the role of vertebrate supraspliceosomes
in gene expression. (A) Co-transcriptional assembly of spliceosomes,
50 end modiﬁcation machinery and other pre-mRNA binding factors on
RNA polymerase II transcripts. (B) The released transcript is partially
spliced and bound by numerous spliceosome moieties as well as the
50 cap-binding complex and 30 end processing factors. (C) The mature
mRNA is associated in the nucleus with RNA binding proteins, 50- and
30-end stabilizing factors (the CBP heterodimer and poly(A)-binding
protein), and proteins that promote export to the cytoplasm.
Nucleic Acids Research, 2007, Vol. 35, No. 12 3929(20 strokes, pestle ‘B’) in a hypotonic solution (30mM
Tris–Cl pH7.5, 10mM KCl, 5mM MgCl2,1 0 m M
2-mercaptoethanol) at 48C. Nuclei were pelleted at
1000 g at 48C for 5min through the hypotonic buﬀer
containing 25% glycerol. The nuclei were washed three
times in the hypotonic buﬀer containing 0.5% Triton
X-100 and once with detergent-free hypotonic buﬀer.
Nuclei were re-suspended in a low-salt buﬀer (LSþ;
10mM Tris–Cl pH7.5, 100mM KCl, 2mM MgCl2,
10mM 2-mercaptoethanol, 0.15mM spermine, 0.05mM
spermidine) and sonicated twice for 20s at the maximum
microtip setting. The resulting nuclear debris was pelleted
at 14000 g for 10s, and the supernatant was layered
onto a 15–45% glycerol gradient (11ml Beckman SW41)
made isotonic to LS- buﬀer (LS buﬀer without
polyamines) and sedimented at 40000 g for 90min.
Fractions (420ml) were collected from the top. Protein and
nucleic acid were separated by phenol/chloroform extrac-
tion and precipitation with acetone (23) (protein) or
ethanol (nucleic acid). Fractions corresponding to the
supraspliceosomes were pooled from six velocity gradients
run in parallel fashion, diluted to  8% glycerol with
LS- buﬀer and incubated with 20mg Y12 antibody which
had been covalently attached to 1g CnBr-sepharose
(GE Biosciences) according to the manufacturer’s instruc-
tions. After incubation with rotation for 2h at 48C, the
sepharose matrix was washed with 200ml LS- buﬀer by
gravity ﬂow in a column and supraspliceosome material
was eluted with 0.2M glycine. Protein and nucleic acids
were separated by phenol/chloroform extraction as
described above.
Purification of chicken supraspliceosomes
Six liters of SmD3-TAP DT40 cells (22) were grown in
Dulbecco’s modiﬁed Eagle media supplemented with 5%
chicken serum and 2.5% Fetalplex (Gemini Bio-Products)
to a density of 7.5 10
5 cells/ml for TAP puriﬁcation.
Cells were harvested by centrifugation (1000 x g for
5min), washed twice with ice-cold PBS, allowed to swell in
10ml of TM buﬀer (10mM Tris–Cl pH7.5, 3mM MgCl2)
with 0.2mM PMSF, 1mg/ml leupeptin, and 1mg/ml
pepstatin for 10min ice, and lysed with 25 strokes of a
Dounce homogenizer at 48C. The nuclei were pelleted and
washed twice with 10ml of TM buﬀer containing 0.1%
NP40, re-suspended in 5ml of low salt buﬀer (30mM
Tris–Cl, 125mM KCl, 5mM MgCl2, 0.5% Triton-X100),
and sonicated at the maximum output, twice for 20s on
ice with 1min in ice between sonications. The sonicated
mixture was centrifuged at 14000 x g for 1min and the
supernatant was used for TAP puriﬁcation. TAP-tagged
protein material for SmD3-TAP DT40 cells was aﬃnity
puriﬁed by the TAP procedure (24). The TEV eluate was
layered onto glycerol gradients and fractionated as
described above for the human supraspliceosomes.
Immunoprecipitations
Polyclonal antisera directed against the carboxyl-terminal
15 amino acids of KIAA0332 and NP_035897 (NCBI
accession numbers) were produced by Genemed Synthesis
and the IgG fraction was partially puriﬁed by ammonium
sulfate precipitation at 50% saturation. Antiserum or
non-immune serum was incubated for 1h at 48C with the
sample(s) of interest prior to addition of 50ml Protein-A
agarose beads. This mixture was incubated one further
hour with rotation at 48C prior to washing with 4 15ml
IPP150. Proteins and nucleic acids were released from
the matrix by incubation in IPP150at 1008C for 5min.
The supernatant was collected and phenol extracted as
described above to harvest, separate and precipitate the
nucleic acids and proteins.
Northern blot analysis
Nucleic acids were transferred to Brightstar membranes
(Ambion) and hybridized with snRNA probes consisting
of antisense chicken snRNAs transcribed with a
32P-GTP
using T7 RNA polymerase (U5) or SP6 RNA polymerase
(U1, U2, U4, U6 snRNAs) from plasmids containing
cDNA versions of the chicken snRNAs.
Western blot analysis
Polypeptides were resolved in 10% polyacrylamide gels
(25), transferred to nitrocellulose membranes (Biorad)
and blotted with antiserum as described in the text. The
secondary antibody used was horseradish peroxidase-
conjugated goat anti-rabbit IgG (Rockland) and the
signal was detected by enhanced chemiluminescence
(Perkin Elmer).
Mass spectrometry peptideidentification
Pooled supraspliceosome protein fractions were separated
by polyacrylamide gel electrophoresis and stained with
Coomassie Blue G-250 (26). Discrete gel slices were
dissected from the top of the gel lane to the bottom and
all regions were subjected to trypsin digestion. Mass
spectrometry and database searching was performed as
previously described (27–29).
RESULTS AND DISCUSSION
Purification of endogenous human pre-mRNA processing
complexes
We discovered that in gently sonicated nuclei treated with
low salt (11), the majority of the snRNA, as judged
by visual inspection of ethidium bromide stained gels
(Figure 2A), was engaged in very large (480S) ribo-
nucleoprotein complexes that closely resemble supraspli-
ceosomes in sedimentation values and other properties
(9,10,30). These particles may also be related to the
polyspliceosomes described in salt-extracted nuclei, which
sedimented as complexes slightly smaller than our supra/
polyspliceosome, likely reﬂecting salt-induced factor loss
during nuclear extraction (12).
For puriﬁcation of the human supraspliceosomes, we
gently sonicated nuclei in a buﬀered low-salt solution and
puriﬁed the material in the  200S region (Figures 2A
and 2B) as previously described (11). This material was
immunopuriﬁed using the antibody Y12 on a solid matrix.
Remarkably, this treatment nearly quantitatively
retained the detectable material from this region of the
glycerol gradient as judged by coomassie gel staining,
3930 Nucleic Acids Research, 2007, Vol. 35, No. 12even after extensive washing, indicating that the majority
of the nuclear contents of this size are Sm-antigen-
containing complexes. The lack of polyribosomes in the
rapidly sedimenting material (as judged by the absence of
5S and 5.8S rRNAs and ribosomal proteins by mass
spectrometry) indicates that the nuclei we prepare are not
contaminated with cytoplasm. The material puriﬁed on a
preparative scale was separated by SDS-PAGE gels of two
compositions to provide optimal resolution of the large
number of polypeptides present (Figure 2C). To demon-
strate the speciﬁcity of these puriﬁcations, gradient-
separated supraspliceosomes were subjected to aﬃnity
chromatography using identical beads and identical
washing and elution conditions, but lacking the Y12
antibody. In Figure S1, we show that from the mock
puriﬁcation, there is no detectable coomassie-stained
material in the resulting protein gel (panel A) and no
snRNAs present (panel B).
Purification of endogenous chicken pre-mRNA
processing complexes
Using our recently developed CLEP tagging procedure
(22), we tagged the SmD3 polypeptide in chicken DT40
cells by introducing a TAP tag (24) at the native genomic
locus. For each experiment, 6l of SmD3-TAP-DT40 cells
were harvested and processed as described for puriﬁcation
of supraspliceosomes from HeLa cells. Aﬃnity chromato-
graphy was performed according to the TAP procedure
(24) and the TEV eluate was sedimented through a
glycerol gradient. The material corresponding to the
supraspliceosomes was isolated; proteins and nucleic
acids are shown in Figures 3A and 3B, respectively. In
Figure S1, we show the proteins (panel C) and RNA
(panel D) resulting from an identical aﬃnity puriﬁcation
procedure performed using extracts from untagged DT40
cells. The absence of proteins, beyond the contaminating
TEV protease, and the absence of snRNAs indicates
that the puriﬁcation is speciﬁc and the proteins identiﬁed
by mass spectrometry are likely to be bona ﬁde supraspli-
ceosome components. Additional conﬁdence is provided
in that there is size-selection as well as one or two steps of
aﬃnity chromatography.
RNA content ofthe supraspliceosomes
RNAs corresponding to the supraspliceosome fractions
from human and chicken cells are shown in Figures 2B
and 3B, respectively. Identities of the RNAs were
conﬁrmed by northern blotting (data not shown). The
presence of all ﬁve spliceosomal snRNAs in this material
Figure 2. Human supraspliceosome-associated polypeptides and
snRNAs. RNA (A) and protein (B) were extracted from preparative
glycerol gradient fractions and electrophoretically resolved through
urea-PAGE (A) or SDS-PAGE (B) gels stained with silver (RNA) or
coomassie blue (protein). Bar below B represents the fractions of
the material pooled for immunopuriﬁcation with Y12 antibody.
(C) Aﬃnity-puriﬁed supraspliceosomal proteins run under two
SDS-PAGE conditions to resolve either large or small polypeptides.
Gels were aligned to show all polypeptides in the aﬃnity-puriﬁed
fractions and are delineated by the marking between them. The entire
gel lanes shown from the two gels in (C) were dissected and each gel
slice was subjected to mass spectrometry protein identiﬁcation.
The proteins identiﬁed are reported under the Hs PS column in
Tables 1–3 and in Supplemental Table S1.
Figure 3. Chicken supraspliceosome-associated polypeptides and
snRNAs. Fractions corresponding to the CLEP-tag puriﬁed, glycerol
gradient-sedimented chicken supraspliceosomes were separated into
protein (A) and RNA (B) fractions and electrophoresed through SDS-
PAGE (A) or urea-PAGE (B) gels and stained with coomassie blue
(protein) or ethidium bromide (RNA). The identities of the snRNAs
are indicated on the right of panel B. The entire gel lane from (A) was
dissected and each gel slice was subjected to mass spectrometry for
protein identiﬁcation. The proteins identiﬁed are reported under the Gg
PS column in Tables 1–3 and in Supplemental Table S1.
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splicing complexes in varying stages of assembly and
activity, as both U1 and U4 snRNAs have been shown to
be released from the spliceosome before the ﬁrst catalytic
step of the splicing reaction in vitro (31–33). Alternatively,
the presence of both U1 and U4 may reﬂect functional
diﬀerences between our preparations and the spliceosomes
assembled in vitro; for example, it is possible that the U1
and U4 snRNAs do not completely dissociate in conjunc-
tion with catalytic activation in vivo, but are only
destabilized and maintained locally. The presence of all
ﬁve snRNAs in roughly equivalent amounts also lends
experimental evidence to the participation of the penta-
snRNP in these functional complexes (19).
Massspectrometry analysis of supraspliceosome-associated
polypeptides
Polyacrylamide gel lanes from the entire human and
chicken supraspliceosome fraction were dissected and the
material analyzed by tandem mass spectrometry (27–29).
Though a wide variety of polypeptides were identiﬁed, it is
notable that we detected very little background contam-
ination of factors known to be unrelated to gene
expression. In Tables 1–4, we categorize the identiﬁed
polypeptides according to function. Remarkably, we
detected 222 distinct polypeptides in the chicken supra-
spliceosomes, and 177 distinct polypeptides in the HeLa
supraspliceosomes. These numbers are signiﬁcantly higher
than the number of polypeptides detected in any one of
the three previously published spliceosome puriﬁcations
(6–8).
The polypeptides identiﬁed by mass spectrometry were
validated by analyzing the percent-coverage for each
protein (Supplemental Table 1). Although there is a
distribution of coverage for the identiﬁed proteins, we
note that while many snRNP-associated factors had a
large percentage of their sequence identiﬁed, some
snRNP-associated proteins had 510% coverage.
Diﬀerences in coverage may reﬂect diﬀerences in abun-
dance, a paucity of appropriately-sized trypsin fragments
or to peculiarities in the mass spectrometry detection of a
particular peptide. The low-coverage of some of the novel
polypeptides that may reasonably be implied to function
in pre-mRNA processing (i.e. contain RNA binding
motifs) may reﬂect their association with a smaller
subset of pre-mRNAs than a general RNA binding
protein such as an hnRNP. In the case of one novel
factor, ZFR, the percent-coverage was low (3.4% for
chicken, 8% for human) but its association with the
splicing machinery was veriﬁed independently (see below).
Known snRNP-associated polypeptides
By mass spectrometry, we identiﬁed nearly all of the
known pre-mRNA splicing snRNP-associated polypep-
tides (Table 1). We were initially surprised by the apparent
absence in our preparations of a subset of snRNP-
associated proteins found in most or all of the previously
puriﬁed spliceosomes. However, upon closer inspection,
we observed that for each polypeptide not represented in
our mass spectrometry results, the inability to be detected
correlated with the presence of an abundant hnRNP
protein of similar molecular weight. The coverage of the
major spliceosomal snRNP proteins was more complete
for the chicken supraspliceosomes. Indeed, the CLEP
tagging and puriﬁcation procedure was sensitive enough
to detect the presence of two minor AT–AC spliceosome
components, the U11/U12–65K and U11/U12–48K poly-
peptides (34) in the chicken fractions, whereas no AT–AC
speciﬁc splicing components were detected in the human
complexes. The ability to detect all of the Sm proteins, but
not all of the LSM proteins may reﬂect the diﬃculty in
detecting all of these proteins in splicing complexes as
shown previously (35,36), the 5-fold abundance diﬀerences
of the two classes of proteins or perhaps due to the LSM
proteins leaving the spliceosome during the process of
pre-mRNA splicing (37).
By western blotting of chicken cell nuclear extracts with
the Y12 monoclonal antibody, we determined that the Sm
antigens in chicken cells were not reactive with the Y12
antibody (data not shown), eliminating the possibility of a
direct comparison between Y12-immunopuriﬁed material
from chicken and human cells.
snRNP biogenesis factors
Previous spliceosome puriﬁcations did not yield polypep-
tides known to be involved in snRNP biogenesis. We note
in Table 1 that there are three of these present in the
chicken supraspliceosomes (SIP1, SMNrp30 and Coilin).
These factors, which are involved in the de novo assembly
of snRNPs, are contained in Cajal bodies (CBs), nuclear
organelles enriched for pre-mRNA splicing factors (38).
We hypothesize that the CLEP tagging procedure may
allow puriﬁcation of a subset of snRNPs in the process of
being re-targeted to the CBs. We did not detect this class
of polypeptides in the HeLa supraspliceosomes. Other
factors present in the chicken supraspliceosome but not
those from HeLa cells were cyclophillins and chromatin
remodeling proteins, which may be related to procedural
diﬀerences in the puriﬁcation methods.
Known spliceosome associated proteins (SAPs)
In the second half of Table 1, we compile a list of the 59
SAPs identiﬁed in one or more of the spliceosome
puriﬁcations. The in vivo-assembled complexes contained
pre-mRNA-interacting factors such as U2AF (39,40),
PTB (41,42), and the cap binding complex proteins (43),
which were present in some but not all of the in vitro-
assembled spliceosomes. We detected the majority of
PRP19-complex (NTC) related components as well,
including homologues of Prp19p (44,45), Syf1p (45),
Syf2p (45), Syf3/Clf1p (45,46), Isy1p (47), SKIP/Prp45p
(48,49) and CDC5/Cef1p (50,51), which were also detected
in vitro, and BCAS2/SPF27, which was only detected in
supraspliceosomes assembled in vivo. Interestingly, our
preparations included a number of polypeptides that are
snRNP-associated in yeast but have not been identiﬁed in
puriﬁed metazoan snRNPs or spliceosomes. Among these
factors are putative orthologues of yeast Prp38p (52),
Prp39p (53), Prp40p (54), Aar2p (55) and Luc7p (56).
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from human or chicken cells and mono-spliceosomes puriﬁed from three in vitro-assembled preparations
ENSEMBL accession #
a HGNC
b Polypeptide
c Gg PS
d Hs PS
e N
f R
g Z
h
U1 snRNP
ENSG00000104852 SNRP70 U1–70K        
ENSG00000077312 SNRPA U1A       
ENSG00000124562 SNRPC U1-C   
U2 snRNP
ENSGALG00000008038 SF3B1 SF3b155       
ENSG00000087365 SF3B2 SF3b145        
ENSGALG00000002531 SF3B3 SF3b130        
ENSGALG00000000581 DDX42 SF3b125   
ENSGALG00000007937 SF3A1 SF3a120       
ENSGALG00000021679 SF3A2 SF3a66        
ENSGALG00000001540 SF3A3 SF3a60        
ENSGALG00000013352 SF3B4 SF3b49       
ENSGALG00000008729 SNRPB2 U2B00        
ENSGALG00000007170 SNRPA1 U2A0        
ENSGALG00000016501 – SF3b14   
ENSGALG00000020000 SF3B5 SF3b10   
U2-snRNP associated
ENSGALG00000014395 DHX15 PRP43/DDX15       
ENSGALG00000002612 – SR140       
ENSGALG00000006332 RBM17 SPF45       
ENSGALG00000008561 SMNDC1 SPF30       
ENSGALG00000003824 CHERP CHERP     
U5, U4/U6 & U4/U6 U5 snRNP
ENSGALG00000002943 PRPF8 U5–220K       
ENSGALG00000003477 ASCC3L1 U5–200K       
ENSGALG00000000988 EFTUD2 U5–116K       
ENSG00000175467 SART1 U4/U6 U5–110K       
ENSGALG00000006001 C20ORF14 U5–102K       
ENSG00000174243 DDX23 U5–100K        
ENSGALG00000000465 PRPF3 U4/U6–90K        
ENSG00000168883 USP39 U4/U6 U5–65K       
ENSG00000105618 PRPF31 U4/U6 U5–61K       
ENSGALG00000008857 PRPF4 U4/U6–60K        
ENSGALG00000004874 PPIH USA–CYP   
ENSGALG00000000615 WDR57 U5–40K    
ENSGALG00000011931 NHP2L1 U4/U6 U5–15.5k     
ENSGALG00000017396 TXNL4A U5–15K   
AT/AC
ENSGALG00000005162 RNPC3 U11/U12–65K  
ENSGALG00000013005 C6ORF151 U11/U12–48K  
Sm/LSM
ENSGALG00000007250 SNRPB SmB/B’        
ENSGALG00000011842 SNRPD1 SmD1       
ENSG00000125743 SNRPD2 SmD2       
ENSGALG00000006596 SNRPD3 SmD3       
ENSGALG00000000137 SNRPE SmE       
ENSGALG00000011409 SNRPF SmF       
ENSG00000143977 SNRPG SmG       
ENSG00000111987 LSM2 LSM2     
ENSG00000170860 LSM3 LSM3   
ENSGALG00000003385 LSM4 LSM4     
ENSG00000106355 LSM5 LSM5
ENSGALG00000009985 LSM6 LSM6       
ENSG00000130332 LSM7 LSM7   
ENSGALP00000014820 LSM8 LSM8     
snRNP biogenesis
ENSGALG00000010154 SIP1 SIP1  
ENSG00000119953 SMNDC1 SMNrp30  
ENSGALG00000003158 COIL Coilin  
SAPs
ENSGALG00000002514 SFPQ PSF     
(Continued)
Nucleic Acids Research, 2007, Vol. 35, No. 12 3933Table 1. Continued
ENSEMBL accession #
a HGNC
b Polypeptide
c Gg PS
d Hs PS
e N
f R
g Z
h
ENSGALG00000002060 FUS TLS/FUS       
ENSGALG00000012468 PRPF39 PRP39  
ENSGALG00000010501 SNW1 SKIP/PRP45         
ENSGALG00000016704 CDC5L CDC5       
ENSGALG00000005012 RAB43 ISY1     
ENSGALG00000008429 CRNKL1 CRN1         
ENSGALG00000009257 PRLG1 Prp46/PRL1     
ENSGALG00000015061 CDC40 CDC40/PRP17     
ENSGALG00000002002 BCAS2 SPF27   
ENSGALG00000013919 PRPF19 PRP19         
ENSGALG00000010627 PRPF38A PRP38   
ENSGALG00000005507 NONO p54nrb   
ENSGALG00000004555 RBM22 ECM2/RBM22     
ENSGALG00000001247 SYF2 SYF2     
ENSGALG00000000726 ELAVL1 ELAV/Hu       
ENSGALG00000009001 – CWC22     
ENSGALG00000008149 EWSR1 EWSR1 (RBP)     
ENSGALG00000004705 BUD31 BUD31     
ENSG00000076924 XAB2 SYF1       
ENSGALG00000001962 PTBP1 PTB     
ENSGALG00000011857 LUC7L2 LUC7/CROP   
ENSG00000196504 PRPF40A PRP40     
ENSGALG00000010167 PNN Pinin   
ENSGALG00000012813 PRPF4B Prp4K       
ENSGALG00000000833 IK RED       
ENSGALG00000001500 – SLU7     
ENSG00000063244 U2AF2 U2AF65         
ENSGALG00000016198 U2AF1 U2AF35         
ENSG00000168066 SF1 SF1    
ENSGALG00000001034 C20ORF4 AAR2  
ENSGALG00000005525 SFRS1 SF2/ASF       
ENSG00000102241 HTATSF1 TAT-SF1  
ENSGALG00000002087 NCBP1 CBC80       
ENSGALG00000006843 NCBP2 CBC20       
ENSG00000087087 – ASR2B   
ENSG00000100296 THOC5 KIAA0983       
ENSG00000159086 C21ORF66 C21ORF66   
ENSG00000126803 HSPA2 HSP70-2       
ENSGALG00000006512 HSPA8 HSP71       
ENSGALG00000009838 AQR Aquarius       
ENSGALG00000002014 SMU1 SMU1       
ENSGALG00000005623 TFIP11 SPP382       
ENSG00000137656 – CWC26   
ENSG00000126698 DNAJC8 SPF31    
ENSG00000105705 SF4 SF4   
ENSG00000113649 TCERG1 CA150       
ENSGALG00000004626 RBM5 E1B-AP5     
ENSG00000100056 DGCR14 DGCR14   
ENSG00000105298 C19ORF29 C19ORF29   
ENSG00000109536 FRG1 FRG1  
ENSG00000171824 EXOSC10 RRP6  
ENSG00000160799 CCDC12 CCDC12/CWF18  
ENSGALG00000011678 DNAJC13 DnaJ     
ENSG00000100813 ACIN1 Acinus     
ENSG00000131051 RNPC2 HCC     
ENSG00000084463 WBP11 WBP11   
ENSG00000196419 XRCC6 Ku70   
aData available at: http://www.ensembl.org.
bHUGO Gene Nomenclature Committee designation, a dash represents a polypeptide which has not yet been assigned a systematic name.
cCommon name.
dGallus gallus supraspliceosome.
eHomo sapiens (HeLa) supraspliceosome.
fNeubauer et al. spliceosome data (8).
gRappsilber et al. spliceosome data (6).
hZhou et al. spliceosome data (7).
f,g,hWere compiled from Jurica and Moore (104).
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of those identiﬁed in the supraspliceosomes with those of spliceosomes formed in vitro
ENSEMBL accession #
a HGNC
b Polypeptide
c Gg PS
d Hs PS
e N
f R
g Z
h
RNA Helicase-like
ENSGALG00000016461 DDX1 DDX1   
ENSGALG00000016231 DDX3X DDX3     
ENSGALG00000003532 DDX5 DDX5/p68       
ENSGALG00000012247 DDX17 DDX17/p72       
ENSGALG00000012147 DDX18 DDX18  
ENSG00000102786 DDX26 DDX26/HDB  
ENSGALG00000006974 DDX27 DDX27  
ENSGALG00000003030 DDX41 DDX41/ABSTRAKT     
ENSG00000123136 DDX39 DDX39  
ENSG00000145833 DDX46 DDX46/PRP5     
ENSGALG00000008530 DDX48 DDX48       
ENSGALG00000004144 DDX50 DDX50/Gu-ß   
ENSGALG00000001186 DHX8 DHX8/PRP22       
ENSG00000135829 DHX9 DHX9/HELICASEA       
ENSG00000137333 DHX16 DHX16/PRP2   
ENSGALG00000005027 DHX30 DHX30   
ENSGALG00000003658 DHX35 DHX35  
ENSG00000174953 DHX36 DHX36  
ENSGALG00000014709 SKIV2L2 SKIV2L2       
ENSG00000198563 BAT1 UAP56     
hnRNP
ENSGALG00000006160 HNRNPA0 hnRNPA0   
ENSGALG00000011036 HNRNPA2B1 hnRNPA2/B1        
ENSG00000135486 HNRPA1 hnRNPA1        
ENSGALG00000009250 HNRNPA3 hnRNPA3       
ENSGALG00000014381 HNRNPAB hnRNPAB   
ENSG00000092199 HNRPC hnRNPC1/C2        
ENSG00000138668 HNRNPD hnRNPD0/AUF1   
ENSGALG00000011184 HNRNPDL hnRNPD0       
ENSG00000169813 HNRPF hnRNPF  
ENSGALG00000006457 RBMX hnRNPG     
ENSGALG00000005955 HNRNPH1 hnRNPH1     
ENSGALG00000003947 HNRNPH3 hnRNPH3   
ENSGALG00000012591 HNRNPK hnRNPK       
ENSG00000104824 HNRNPL hnRNPL       
ENSGALG00000000377 HNRNPM hnRNPM      
ENSGALG00000015830 SYNCRIP hnRNPQ       
ENSGALG00000000814 HNRNPR hnRNPR       
ENSGALG00000010671 HNRNPU hnRNPU     
ENSGALG00000018665 – hnRNP novel  
ENSG00000126457 HRMT1L2 HRMT1L2  
SR family
ENSG00000133226 SRRM1 SRm160   
ENSG00000167978 SRRM2 SRm300   
ENSGALG00000005525 SFRS1 SF2p33  
ENSG00000161547 SFRS2 SC35   
ENSGALG00000000533 SFRS3 SFRS3SRp20       
ENSG00000116350 SFRS4 SRp75  
ENSGALG00000009484 SFRS5 SRp40   
ENSGALG00000000990 SFRS6 SRp55       
ENSGALG00000013825 SFRS7 9G8       
ENSGALG00000002487 SFRS8 SFRS8  
ENSG00000111786 SFRS9 SRp30     
ENSGALG00000006531 SFRS10 SFRS10     
ENSG00000116754 SFRS11 SRp54   
ENSG00000153914 SFRS12 SFRS12  
ENSGALG00000004133 FUSIP1 SRrp35   
Cyclophillins
ENSGALG00000013383 PPIE CYP-E     
ENSGALG00000004874 PPIH USA-CYP  
ENSGALG00000014747 SDCCAG10 CYP16   
ENSG00000137168 PPIL1 PPIL1/CWF27     
ENSG00000100023 PPIL2 PPIL2/CYP60     
ENSG00000115934 PPIL3 PPIL3B   
ENSG00000113593 PPWD1 PPWD1     
(Continued)
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ENSEMBL accession #
a HGNC
b Polypeptide
c Gg PS
d Hs PS
e N
f R
g Z
h
RBP
ENSG00000102317 RBM3 RBM3  
ENSGALG00000018992 RBM4B RBM4B/Lark  
ENSGALG00000004626 RBM5 RBM5   
ENSGALG00000007017 RBM7 RBM7   
ENSG00000131795 RBM8A RBM8B   
ENSGALG00000013411 RBM14 RBM14   
ENSG00000162775 RBM15 RBM15     
ENSGALG00000002372 RBM15B RBM15B   
ENSG00000197676 RBM16 RBM16  
ENSGALG00000004555 RBM22 RBM22  
ENSG00000119707 RBM25 RBM25  
ENSG00000091009 RBM27 RBM27  
ENSGALG00000011038 CBX3 RNPS1   
ENSG00000033030 ZCCHC8 ZFP8   
ENSGALG00000006113 ZNF326 ZFP326   
ENSG00000179950 – PUF60     
ENSG00000197381 ADARB1 ADAR1  
ENSG00000160710 ADAR ADAR2  
ENSGALG00000010952 – Requiem  
ENSGALG00000011570 ILF2 NFAT45       
ENSG00000129351 ILF3 NFAT90       
ENSG00000169564 PCBP1 PolyrCBP  
ENSGALG00000012225 CIRBP CIRBP   
ENSG00000056097 ZFR ZFR   
ENSGALG00000009427 TIAL1 TIA1  
ENSGALG00000001187 STRBP STRBP  
ENSG00000136231 IGF2BP3 IMP3       
ENSG00000060138 CSDA CSDA   
ENSG00000121774 KHDRBS1 SAM68  
ENSG00000126254 - Novel RRM  
ENSG00000132773 TOE1 TOE1  
ENSG00000142864 SERBP1 SERBP1  
Export/transcription/NMD
ENSGALG00000014915 THOC1 THO1/HPR1   
ENSGALG00000008507 THOC2 THO2       
ENSG00000051596 THOC3 THO3/TEX1   
ENSGALG00000007237 THOC4 THO4/ALY       
ENSGALG00000004571 PPP1CA GLC7/PPP1CA  
ENSGALG00000002569 RAN Ran   
ENSG00000119392 GLE1L GLE1L  
ENSGALG00000007653 RAE1 GLE2/RAE1   
ENSGALG00000003220 RENT1 UPF1/RENT  
ENSG00000131795 RBM8A Y14/RBM8A     
ENSGALG00000002144 THRAP3 TRAP150   
ENSG00000172660 TAF15 TAF15/RBP56  
ENSG00000162231 NXF1 TAP  
ENSG00000065978 YBX1 YBX1     
ENSGALG00000010689 MAGOH Mago nashi     
30 end proc.
ENSG00000071894 CPSF1 CPSF1  
ENSGALG00000010783 CPSF2 CPSF2  
ENSGALG00000016424 CPSF3 CPSF3   
ENSGALG00000004714 CPSF4 CPSF4  
ENSGALG00000003084 CPSF5 CPSF5     
ENSG00000111605 CPSF6 CPSF6   
ENSGALG00000011685 CSTF3 CSTF-77   
ENSGALG00000013943 FIP1L1 FIP1  
ENSG00000172239 PAIP1 PAIP1  
ENSG00000100836 PABPN1 PABPN1       
ENSGALG00000003800 PABPC4 PABPC4  
aData available at: http://www.ensembl.org.
bHUGO Gene Nomenclature Committee designation, a dash represents a polypeptide which has not yet been assigned a systematic name.
cCommon name.
dGallus gallus supraspliceosome;
eHomo sapiens (HeLa) supraspliceosome.
fNeubauer et al. spliceosome data (8).
gRappsilber et al. spliceosome data (6).
hZhou et al. spliceosome data (7).
f,g,hWere compiled from Jurica and Moore (104).Table 3. Structural, nucleoporin and novel polypeptides present in the supraspliceosomes and in vitro-assembled splicing complexes
ENSEMBL accession #
a HGNC
b Polypeptide
c Gg PS
d Hs PS
e N
f R
g Z
h
Structural
ENSGALG00000012533 MYH9 Myosin   
ENSGALG00000009126 TTN Titin  
ENSGALG00000001381 ACTG1 Actin   
ENSGALG00000002478 MATR3 MATRIN3       
ENSGALG00000008677 VIM Vimentin   
ENSG00000117245 KIF17 Kinesin KIF17  
ENSGALG00000002197 NPM1 NUMATRIN     
ENSGALG00000014692 LMNB1 Lamin B   
ENSGALG00000013505 SYNE1 NuSpectrin   
ENSG00000140259 MFAP1 MFAP1   
Chromatin modiﬁcation
ENSGALG00000000360 ARID1A ARID1A-SWI/SNF  
ENSGALG00000013683 ARID1B ARID1B-SWI/SNF  
ENSGALG00000010164 SMARCA2 SMARCA2  
ENSG00000127616 SMARCA4 Brahma/SMARCA4  
ENSGALG00000009913 SMARCA5 SMARCA5  
ENSGALG00000005983 SMARCB1 SMARCB1  
ENSGALG00000005048 SMARCC2 BRG1-SWI/SNF  
ENSGALG00000005048 SMARCC1 SMARCC1  
ENSGALP00000010010 SMARCD1 SMARCD1  
ENSGALG00000000363 SMARCD2 SMARCD2  
ENSGALG00000002100 SMARCE1 SMARCE1  
Nucleoporins
ENSGALG00000005714 PKD1 PKD1 (NUP assoc)  
ENSGALG00000003830 NUP214 NUP214   
ENSGALG00000012720 NUP153 NUP153  
ENSGALG00000005078 NUP210 NUP210   
ENSG00000102900 NUP93 NUP93  
ENSG00000108559 NUP88 NUP88  
ENSG00000111581 NUP107 NUP107  
ENSG00000110713 NUP98 NUP98  
ENSG00000138750 NUP54 NUP54  
ENSG00000163002 NUP35 NUP35  
ENSG00000069248 NUP133 NUP133  
ENSG00000155561 NUP205 NUP205  
Novel or unknown to splicing
ENSGALG00000011351 HSP90AA1 HSP90a   
ENSGALG00000010175 HSP90AA2 HSP90ß   
ENSGALG00000012726 HSP90B1 HSP108   
ENSGALG00000009967 LRPPRC LRP130  
ENSGALG00000003693 MACF1 Macrophin  
ENSGALG00000007705 NCL Nucleolin  
ENSGALG00000015933 C21ORF66 GCRBF  
ENSGALG00000008454 – NOP58  
ENSGALG00000009061 ACTL6A BAF53A  
ENSGALG00000007520 SSRP1 FACT80   
ENSGALG00000015821 CCT8 TCP1-theta  
ENSGALG00000014500 NOL5A Nol5A/NOP56  
ENSGALG00000005624 MED12 TRAP230  
ENSGALG00000010973 TRA2A TRA2a   
ENSGALG00000008372 XRN2 RAT1   
ENSG00000197157 – SND1   
ENSGALG00000001948 SAFB2 SAFB/HSP27   
ENSGALG00000003177 BRD8 BRD8   
ENSGALG00000010699 – FOG  
ENSGALG00000005177 C9ORF10 C9ORF10   
ENSGALG00000002653 – ELG   
ENSGALG00000016949 WBP4 WBP4  
ENSGALG00000004133 FUSIP1 Fus IP   
ENSGALG00000017384 ERH ERH   
ENSG00000079246 XRCC5 Ku80  
ENSG00000182562 ATAD3A ATAD3A (AAA ATPase)   
ENSGALG00000001515 ATAD3B ATAD3B (AAA ATPase)   
ENSG00000108588 CCDC47 CCDC47  
aData available at: http://www.ensembl.org.
bHUGO Gene Nomenclature Committee designation, a dash represents a polypeptide which has not yet been assigned a systematic name.
cCommon name.
dGallus gallus supraspliceosome.
eHomo sapiens (HeLa) supraspliceosome.
fNeubauer et al. spliceosome data (8).
gRappsilber et al. spliceosome data (6).
hZhou et al. spliceosome data (7).
f,g,hWere compiled from Jurica and Moore (104).Other polypeptides exclusively contained in the puriﬁed
supraspliceosomes include, NONO/p54nrb, PNN/Pinin,
CWC22, which have been previously implicated in splicing
(57–60). Conversely, 13 polypeptides were exclusively
associated with the in vitro puriﬁed spliceosomes, possibly
reﬂecting speciﬁcity for the pre-mRNAs upon which these
were assembled. Alternatively, the diﬀerences in composi-
tion may result from diﬀerences in the procedures. Most
striking, however, is the absence of SF1/BBP from our
supraspliceosome preparations. This may be due to the
fact that SF1/BBP interacts very early with the pre-
mRNA, remains associated for a short time and is
replaced by U2 snRNP at the branchpoint sequence (61).
RNA helicase-like proteins
We identiﬁed a large number of DExH/D proteins in the
preparations of supraspliceosome assembled in vivo.I n
addition to the RNA helicase-like polypeptides known to
function in pre-mRNA splicing, such as DDX15/Prp43p
(62–64), DHX8/Prp22p (65–67), DDX46/Prp5p (68–70),
DDX5/p68 and DDX17/p72 (71), UAP56/Sub2p (72–74),
DDX16/Prp2p (75,76) and the snRNP-associated heli-
cases U5-200K/Brr2p (77–79) and U5-100K/Prp28p
(80–82), we noted a number not previously implicated in
pre-mRNA splicing and absent from the in vitro puriﬁed
spliceosomes [Table 2 (‘Gg’ and ‘Hs’ to ‘N’, ‘R’ and ‘Z’)].
These include 13 additional polypeptides with sequence
motifs indicative of DEAD, DEAH or Ski2p-like helicase
family members, most of which were absent from
spliceosomes assembled in vitro. Although we do not as
yet have evidence that these proteins function in pre-
mRNA splicing, the complete absence of DNA helicases
in our preparations indicates a speciﬁcity (i.e. a speciﬁcity
for RNA processing complexes and against chromatin
components), which minimally suggests that they function
in some aspect of RNA Pol II transcript processing.
Supraspliceosome-associated hnRNPs
Polypeptides termed hnRNPs are highly abundant nuclear
proteins known to interact with hnRNA. We detected
virtually all of the known hnRNP proteins in both human
and chicken cells, as well as other hnRNP-like proteins
annotated in genome databases (Table 2). We note that in
the spliceosomes puriﬁed from in vitro extracts, some
hnRNPs were identiﬁed; however, perhaps owing to
speciﬁc binding of some hnRNPs to the bulk hnRNA
and not the single transcript used in the in vitro
spliceosome assembly reactions, a greater number of
these polypeptides were detected in the supraspliceosomes.
SR proteins
Many splicing factors are rich in arginine and serine
residues including long stretches of alternating dipeptides
termed SR domains. These factors function at multiple
steps in the pre-mRNA splicing pathway (83), and were
constituents of the in vitro-puriﬁed splicing complexes. We
detected 10 diﬀerent SR family members in our puriﬁed
supraspliceosomes from both chicken and human cells
(Table 2), though not a complete set. One possible
conclusion is that, due to the means by which these
complexes were puriﬁed and analyzed, these SR proteins
represent the major SR proteins functioning in these cells,
and that those not detected in our preparations function in
the splicing of a smaller subset of pre-mRNAs.
Cyclophillins
In addition to the known snRNP-associated USA–CYP
(84,85), we detected ﬁve additional potential proline cis-
trans isomerases co-purifying with spliceosomes from
chicken, but interestingly, not from HeLa cells. Several
of those from the chicken puriﬁcation were also present in
spliceosomes assembled in vitro (Table 3). As it is likely
that these proteins also function in HeLa cells, their
absence may represent operational diﬀerences in the ways
in which the chicken and human cells were handled and
the ways in which the complexes were puriﬁed and
analyzed.
Table 4. Known pre-mRNA processing proteins not present in any puriﬁed splicing complex
ENSEMBL accession #
a HGNC
b Polypeptide
c
ENSG00000095485 CWF19L1 CWF19
ENSG00000152404 CWF19L2 CWF19
ENSG00000165630 PRPF18 PRP18
ENSG00000140829 DHX38 PRP16
ENSG00000149532 – CFI-59K
ENSG00000165494 PCF11 PCF11
ENSG00000172409 CLP1 CLP1
ENSG00000111880 HCAP1 HCE/CEG1
ENSG00000146007 ZMAT2 SNU23
ENSG00000108296 CCDC49 CWC25
ENSG00000101138 CSTF1 CSTF-50
ENSG00000101811 CSTF2 CSTF-64
ENSG00000161981 C16ORF33 U11/U12–25K
ENSG00000184209 – U11/U12–35K
aData available at: http://www.ensembl.org.
bHUGO Gene Nomenclature Committee designation, a dash represents a polypeptide which has not yet been assigned a systematic name.
cCommon name.
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There were 32 polypeptides identiﬁed among all of the
splicing complex puriﬁcations possessing sequence homol-
ogy to polypeptides believed to interact with RNA by
virtue of containing RNA Recognition Motifs (RRM),
double-stranded RNA binding domains (dsRBD) or other
motifs implicated in RNA binding. Some were identiﬁed
previously, such as the ELAV/Hu protein that binds AU-
rich elements in both cytoplasmic (86) and nuclear RNAs
(87), the U2AF-related PUF60 protein (88), the dsRBD-
motif-containing NFAT45 and NFAT90 and RNA
adenosine deaminases; these were previously shown to
exist in large nuclear complexes (16) and believed to
function in RNA Pol II transcript metabolism. Only a
single predicted RNA binding protein was found in the
in vitro-assembled splicing complexes but not in either
the chicken or HeLa supraspliceosomes, while 22 were
exclusively found in supraspliceosomes, but not in the
in vitro-formed complexes. We believe this is most likely
due to the use of a single pre-mRNA in vitro, while
a broader spectrum of RNA binding proteins will be
associated with bulk pre-mRNA. In Figure 4 we present
a graphical representation of the 16 presumptive RNA
binding proteins novel to our study and highlight the
sequence motifs contained in each.
Non-spliceosomal pre-mRNA processing factors
Cap-binding proteins (CBC80 and CBC20) are present in
both spliceosomes assembled in vitro and supraspliceo-
somes assembled in vivo (Table 1). In Table 2, we report
the presence in our preparations of many 30 end processing
factors (CSPF, CSTF and poly-A binding proteins), a
comprehensive set of proteins shown to be involved in
mRNA export including the TREX complex (THO1/
HPR1, THO2, THO3/TEX1, UAP56 and ALY) (89),
export factors such as TAP (90,91), GLE1 (92), GLE2 (93)
and GLC7 (94), and exon junction complex constituents
including Y14 and Magoh. We also note that a single
component of the nonsense-mediated decay (NMD)
pathway (UPF1) (95) was identiﬁed in the chicken
material. As NMD is likely to be active only in a very
small subset of pre-mRNA processing complexes (96),
we were surprised to observe even a single polypeptide
implicated in this process.
Nuclear matrix and filament proteins
Recent data from several laboratories suggest a functional
interaction between the structural proteins of the nuclear
matrix and the gene expression machinery (97). Consistent
with this model, we detected a number of nuclear matrix
proteins in our endogenously formed pre-mRNA splicing
complex preparations including actin, spectrin, matrin3,
numatrin, lamin B and a matrix associated protein MAP1.
Although we cannot conﬁrm the functional relevance of
these associations, we note that a few structural proteins
also co-puriﬁed with in vitro-assembled spliceosomes. We
also note that a number of hnRNPs and other known
splicing factors such as Prp19p (98) were initially termed
nuclear matrix-associated proteins, indicating an intimate
relationship between the pre-mRNA processing machin-
ery and the nuclear matrix. Indeed, it is an attractive
hypothesis that pre-mRNA and mRNA are traﬃcked to
the nuclear pore via the nuclear matrix.
Nuclear pore complexproteins
A substantial number of nucleoporins (NUPs) are present
in the puriﬁed supraspliceosome complexes from human
cells but not in spliceosomes assembled in vitro, which may
perhaps be due to our use of sonication to release
complexes from the puriﬁed nuclei versus salt extraction
for preparation of splicing extracts. In the chicken
supraspliceosomes, we detected a smaller set of NUPs,
which may be due to their release by the detergent NP40
present during puriﬁcation of these complexes. NP40 was
absent during the puriﬁcation of the human complexes,
which likely maintained the integrity of hydrophobic
interactions believed to stabilize the interaction of export
complexes with NUPs.
Polypeptidesnoveltopre-mRNAsplicing–SWI/SNFproteins
andassociated factors
A recent report from Muchardt and colleagues (99) has
demonstrated that the SWI/SNF component Brahma/
SMARCA4 (Brm) associates with the splicing apparatus
and its presence favors the inclusion of alternatively
spliced exons. The Prp4 kinase, which is present in both
the human and chicken supraspliceosomes, has been
reported to phosphorylate both Brm and the splicing
factor U5–102K/hPrp6 (100) providing further evidence
that it functions in Pol II transcript maturation. In the
puriﬁed chicken supraspliceosomes, Brahma/SMARCA4,
Figure 4. Novel spliceosome-associated polypeptides with predicted
RNA binding motifs. Polypeptides from Table 2 with no known
function in the pre-mRNA processing pathway are shown with
graphical representations of the various RNA interaction or other
noted motifs listed at the bottom of the Figure.
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were identiﬁed (Table 3), all with high degrees of
conﬁdence given the depth of the peptide identiﬁcation.
As our mass spectrometry data neither included structural
proteins of chromatin- such as histones, nor the DNA
replication machinery or other DNA binding proteins,
Brahma and other polypeptides with chromatin-related
functions must speciﬁcally associated with the pre-mRNA
processing complexes.
Novelpolypeptides present innative supraspliceosomes
Our mass spectrometry peptide data revealed several novel
and intriguing polypeptides in the supraspliceosome
complexes (Table 3). We found chicken homologs of the
yeast splicing factors Prp38p, Prp39p and Aar2p, pre-
viously unannotated in puriﬁed pre-mRNA splicing
complexes. The other polypeptides of interest in the
endogenous splicing complexes include the 50 to 30
exonuclease XRN2/Rat1p (101–103), which has been
implicated in linking transcription termination with
polyadenylation. XRN2/Rat1p was found in both the
human and chicken preparations, as were two unchar-
acterized AAA ATPases, ATAD3A and ATAD3B. The
identities of 25 additional novel polypeptides are reported
in Table 3.
Co-immunoprecipitation of spliceosomal components by
antiserumdirected againstanovel polypeptide
To demonstrate the authenticity and functional relevance
of a novel polypeptide that co-puriﬁed with endogenous
spliceosomes, we generated antiserum against ZFR
(Table 2) and used it to speciﬁcally immunopurify ZFR-
associated components. In Figure 5A, we show that the
ZFR polypeptide is present in very high molecular weight
complexes that co-migrate with supraspliceosomal mate-
rial. In Figure 5B, we show that the anti-ZFR antiserum,
but not the pre-immune serum or the Protein-A beads,
immunoprecipitates the U1, U2, U4, U5 and U6 snRNAs.
As a positive control, we showed that antiserum directed
against the known spliceosomal protein SR140, prepared
and analyzed under identical conditions, also immuno-
precipitated all of the snRNAs. We also tested for the
presence of another pre-mRNA splicing factor, hPrp43
(DHX15), in the material immunopuriﬁed with anti-ZFR;
Figure 5C shows that the speciﬁc antiserum, but not the
pre-immune serum or the Protein-A beads, immunopre-
cipitates hPrp43p/DDX15. This demonstrates that the
novel spliceosome-associated factor ZFR is indeed asso-
ciated with spliceosomal snRNAs and other spliceosomal
proteins.
We note that there are snRNA stoichiometry diﬀerences
between the two immunoprecipitations. Although we
cannot be certain of exactly why this is, it may be that
the ZFR polypeptide is associated with a number of
diﬀerent complexes, as is almost certain from its distribu-
tion in the glycerol gradient. As the immunoprecipitations
were performed using nuclear extracts, and not size-
selected complexes, the snRNA representation reﬂects the
ZFR-associated material from the entire nucleus and not
solely from the polyspliceosomes.
In this work, we report the composition of the
endogenous pre-mRNA processing machinery from
human and chicken cells and provide a comparison
between native supraspliceosome complexes and spliceo-
somes assembled on a model single-intron substrate in
vitro from salt-extracted nuclear material. These supras-
pliceosomes have recently been shown to be functional in
add-back experiments using micrococcal nuclease-treated
extracts for in vitro splicing by Sperling and colleagues
(21), further enhancing the functional relevance of
our ﬁndings. In addition to conﬁrming the set of factors
known to interact with Pol II transcripts during splicing,
we discovered an extensive array of novel factors by
purifying supraspliceosomes from two types of vertebrate
cells. Many of these have been implicated in pre-mRNA
maturation including a subset of the SWI/SNF chromatin
remodeling complex proteins, recently shown to inﬂuence
alternative splicing patterns and to co-purify with pre-
mRNA splicing factors. The novel polypeptides discov-
ered in the endogenous complexes will provide a rich
source of new proteins to investigate, ultimately enhancing
our understanding of this incredibly complex macromo-
lecular machine.
Comparison with invitro-assembled spliceosomes
In Tables 1–3 we present a comparison of the polypeptides
present in the supraspliceosomes puriﬁed in this work
with those puriﬁed in previous in vitro spliceosome
preparations. The core machinery (snRNPs, SAPs,
Figure 5. The novel Zn ﬁnger protein ZFR is a bona ﬁde spliceosomal
component. (A) ZFR sediments with the 200S particle in glycerol
gradients. HeLa nuclear extract was subjected to glycerol velocity
gradient sedimentation analysis as in Figure 2. Proteins from the
indicated fractions were electrophoresed through SDS-PAGE gels and
subjected to western blot analysis using anti-ZFR antiserum. The bar
below the gel denotes the 200S region. (B) ZFR is speciﬁcally
associated with spliceosomal snRNAs. Equal amounts of HeLa nuclear
extract were incubated with protein-A beads (beads), pre-immune
serum and protein-A beads (pre-immune), anti-ZFR antiserum and
protein-A beads (anti-ZFR) or anti-SR140 antiserum and protein-A
beads (anti-SR140) according to the Materials and Methods. Recovered
nucleic acids were subjected to northern blot analysis and probed with
antisense probes to human snRNAs (identities noted to the right of the
Figure). (C) ZFR is speciﬁcally associated with complexes containing
spliceosomal proteins. Immunoprecipitation conditions and lanes are as
described in (B). Proteins were subjected to western blot analysis using
hPrp43 antiserum.
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derived from all of the puriﬁcation schemes. However, a
great many other factors are present in all of the
preparations as well, highlighting the amazing number
of proteins required to remove even the single intron used
in the in vitro experiments. The methods used for the
puriﬁcation of all of the complexes represented in Tables
1–3 were operationally distinct and the in vivo-assembled
spliceosomes contained a larger number of proteins than
did the spliceosome preparations formed in vitro.
What is perhaps most remarkable about our results is
the fact that, despite the operationally distinct puriﬁcation
strategies, the basal pre-mRNA processing machinery
required to eﬀect the removal of a single intron in vitro is
not vastly diﬀerent than that puriﬁed from complex
mixtures of all of the pre-mRNAs in a vertebrate or
human nucleus. The major diﬀerences in composition
between the previous puriﬁcations and the one described
herein involve (i) polypeptides predicted by sequence
homology to interact with the pre-mRNA (ii) the depth of
coverage for polypeptides involved in export and 30 end
processing and (iii) polypeptides that may require that the
pre-mRNA in these complexes follow the path of RNA
Pol II transcription and nuclear traﬃcking, such as the
SWI/SNF complexes, structural proteins and NUPs.
Pre-mRNAprocessingfactorsnotpresentinanyspliceosome
purification
To complete the catalog of polypeptides that participate in
the nuclear pre-mRNA processing pathway, we have
compiled a list of factors know to function in processing
of RNA Pol II transcripts, but not present in any of the
ﬁve spliceosome preparations listed in Tables 1–3. In
Table 4, we outline this relatively short list of 14 factors.
Table 4 does not include factors implicated in yeast
splicing, but for which no identiﬁable human or vertebrate
homologue in the genomic databases. By adding together
all of the polypeptides listed in Tables 1–4, we arrive at
an estimate of at least 305 for the number of proteins that
co-purify with endogenous pre-mRNA splicing com-
plexes. This is by far the largest cataloguing of factors
potentially required for or participating in this process to
date.
Two possible classes of polypeptides may exist that are
not detected in our preparations. First are those that are
underrepresented because they may interact with only a
small number of pre-mRNAs, such as intron- or exon-
speciﬁc binding proteins. Other classes of proteins which
may participate in pre-mRNA splicing but as absent from
our analyses might include tissue-type developmental
stage-speciﬁc factors which would not be present in our
bulk supraspliceosome preparations due to the use of only
two cell types. To date, such factors have generally been
elucidated via genetic or molecular strategies focused on
individual pre-mRNAs. However, with the introduction of
the CLEP tagging technology to more cell types (22), it
may be possible to rapidly enumerate factors that function
in regulated or alternative splicing.
Although we cannot completely eliminate the possibility
that there may be contaminants present in our
preparations, the basic strategy we adopted is validated
by the presence proteins such as Brahma that were not
detected in the previously characterized in vitro-assembled
spliceosomes yet have clearly been implicated in splicing
through other means. Our analyses in aggregate greatly
expand our knowledge of the protein factors that function
both in basal and regulated splicing in vertebrate cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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